Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Real-world effectiveness and treatment costs of ceftazidime–avibactam versus colistin–meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients
Publication with shared reference
10.1007/s10096-026-05677-0
Home
Publications
Real-world effectiveness and treatment costs of ceftazidime–avibactam versus colistin–meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients
Publication with shared reference
10.1007/s10096-026-05677-0
Publications with shared reference:
Real-world effectiveness and treatment costs of ceftazidime–avibactam versus colistin–meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients
0
publications found
Export
Export
Analytics view
Analytics view
Scroll to top